This feature would allow clinicians or researchers to input patient-specific data to visualize predicted outcomes based on the varying dosages used in the trials.
: A dynamic "Pre-Administration" list that cross-references the patient's current medications with contraindications (like other drugs that impair hemostasis) to prevent fatal bleeding. The EXTEND-IA TNK Part 2 Randomized Clinical Trial - PubMed Download LABSJDM UIA TNK zip
If you are developing a "feature" for this specific data package or a related application, a powerful addition would be an . Feature: Automated Dosage & Outcome Predictor This feature would allow clinicians or researchers to
: Automatically flags if a dosage exceeds the max caps (e.g., the 40mg limit for or 25mg for used in Phase 2). Download LABSJDM UIA TNK zip